Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-25

Clinical Trial Update: A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing [NA]

View source ↗

Summary

This clinical trial update outlines an ongoing study evaluating whether a second transurethral resection is necessary in high-risk non-muscle-invasive bladder c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Non Muscle Invasive Bladder Cancer | NA | Status: RECRUITING